Erin K. Brenner

Insider Reports History

Location
Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin K. Brenner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Chief Product Dev. Officer Restricted Stock Units 952,380 15 Feb 2023 Direct

Insider Reports Filed by Erin K. Brenner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299323004044-brenner-erin-k-2023-02-15 Pear Therapeutics, Inc. 15 Feb 2023 1 $0 4 Chief Product Dev. Officer 17 Feb 2023, 15:14
/report/000106299323001327-brenner-erin-k-2023-01-20 Pear Therapeutics, Inc. 20 Jan 2023 1 -$9,820 4 Chief Product Dev. Officer 24 Jan 2023, 15:08
/report/000106299323001046-brenner-erin-k-2023-01-14 Pear Therapeutics, Inc. 14 Jan 2023 2 $0 4 Chief Product Dev. Officer 18 Jan 2023, 17:42
/report/000106299322023633-brenner-erin-k-2022-12-09 Pear Therapeutics, Inc. 09 Dec 2022 2 +$15,000 4 Chief Product Dev. Officer 09 Dec 2022, 16:02
/report/000106299322013687-brenner-erin-k-2022-05-25 Pear Therapeutics, Inc. 25 May 2022 2 +$15,000 4 Chief Product Dev. Officer 27 May 2022, 16:02
/report/000106299322004984-brenner-erin-k-2022-02-16 Pear Therapeutics, Inc. 16 Feb 2022 2 $0 4 Chief Product Dev. Officer 18 Feb 2022, 15:44
/report/000106299321012394-brenner-erin-k-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 6 $0 4 Chief Product Dev. Officer 07 Dec 2021, 16:24
/report/000106299321012369-brenner-erin-k-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 0 $0 3 Chief Product Dev. Officer 07 Dec 2021, 16:10